Press Release

Global Guillain-Barre Syndrome Treatment Market to Gain Traction; FDA Clears CSL’s Immunoglobulin, Privigen

With the Guillain-Barre syndrome becoming increasingly prevalent, the global Guillain-Barre syndrome market expansion is poised to progress steadily in the forecast period. Fortune Business Insights shares valuable market analysis in its report, titled “Guillain-Barre Syndrome Treatment Market Size, Share and Global Trend By Type (Acute Inflammatory Demyelinating Polyradiculoneuropathy, Miller Fisher Syndrome, Acute Motor Axonal Neuropathy, Acute Motor-Sensory Axonal Neuropathy), By Treatment (Plasmapheresis, Immunoglobulin therapy, Others), By Route of Administration (Oral, Parental), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others) and Geography Forecast till 2026”.

Browse Complete Report Details at

In the report is also contained a comprehensive evaluation of the factors that will influence the market and the probable market trends that will emerge.

Some of the major companies that are present in the Global Guillain- Barre Syndrome Market are

  • Grifols S.A.
  • CSL Behring LLC
  • Shire plc,
  • Octapharma AG,
  • Nihon Pharmaceutical Co., Ltd.
  • Akari Therapeutics, PLC
  • China Biologic Products Holdings, Inc.
  • Biotest AG, and others

Guillain-Barre syndrome is an autoimmune disease that is rare and occurs when the body’s immune system begins attacking the healthy nerve cells in the peripheral nervous system. This results in numbness, weakness, and eventual paralysis. Researchers have been unable to find a definite cause; but, many experts are of the opinion that the disease is triggered by infection to the lungs or the gastric region. The most common type of Guillain-Barre syndrome is the Acute Inflammatory Demyelinating Polyradiculoneuropathy, which affects the myelin.

Staggering Rate of Increase to Propel Market Growth

The global Guillain-Barre syndrome treatment market is up for robust growth owing to the astonishing increase in the prevalence of the disease. According to a study published jointly by the US National Library of Medicine, the National Institutes of Health, and PLOS One Journal, approximately 100,000 new cases of the Guillain-Barre syndrome are registered annually. While the numbers are disturbing, they signal good news for the global Guillain-Barre syndrome treatment market, which will see considerable expansion as a result in the coming decade.

Get Sample PDF Brochure at

Possible Links with Dengue and Zika Virus May Aid the Market

A study published by PLOS One revealed that the Guillain-Barre syndrome is associated with the Zika and Chikungunya virus. In some cases, the onset of the disease was preceded by a dengue infection in the patient. The Centre for Disease Control and Prevention believes that an improper and insufficient response by the immune system to such infections triggers the syndrome. With frequent epidemics of dengue, zika, and chikungunya, especially in tropical countries, the global Guillain-Barre syndrome treatment market is poised to gain substantially during the forecast period.

Low Awareness Levels to Hinder Market Growth

Awareness levels regarding Guillain-Barre syndrome are low across the globe, particularly in low and middle-income countries. Moreover, the medication to treat the disease is expensive and vague, while insurance policies do not sufficiently cover the treatment procedures. All these factors are expected to play a restraining role on the global Guillain-Barre syndrome treatment market in the forecast period.

Regulatory Approvals for Innovative Products to Boost Market Investment

Spain-based Grifols S.A. has been developing Flebogamma, an immunoglobulin to treat various autoimmune diseases, including Guillain-Barre syndrome and Kawasaki Disease. The medicine recently got approval by the European Medicines Agency to launch it commercially in the European market. Such regulatory approvals bode well for the global Guillain-Barre syndrome treatment market as other key players will be encouraged to invest in research and develop new products.

According to Fortune Business Insights, the important players in the global Guillain-Barre syndrome treatment market include Akari Therapeutics, PLC, Biotest AG, Octapharma AG, CSL Behring LLC, China Biologic Products Holdings, Inc., Grifols S.A., among others.

Speak To Analyst at

North America to Hold Dominant Market Share; Asia-Pacific to Boast an Impressive CAGR

Presence of major market players, increasing investment in research, and a well-entrenched healthcare infrastructure will put North America in a dominant position in the global Guillain-Barre syndrome treatment market. Increasing incidence of bacterial infections such as diarrhoea is also expected to boost the market in North America. In terms of CAGR, Asia-Pacific is anticipated to register a high growth rate in the global Guillain-Barre syndrome treatment market till 2026. This is owing to growing awareness of the disease in developing countries such as India and China, a large patient pool, rising epidemic rates of viral infections.


What is the market size and growth rate of the global and regional market by various segments?

What is the market size and growth rate of the market for selective countries?

Which region or sub-segment is expected to drive the market in the forecast period?

What Factors are estimated to drive and restrain the market growth?

What are the key technological and market trends shaping the market?

What are the key opportunities in the market?

What are the key companies operating in the market?

Which company accounted for the highest market share?

Why Choose Fortune Business Insights?

More Trending Topics from Fortune Business Insights:

Essential Oils Market Key Factor Analysis with Top Players: Biolandes SAS, Now Foods, International Flavors & Fragrances Inc., and more

Cosmetic Dentistry Market 2019 Global Size, Growth Insight, Share, Trends, Industry Key Players, Regional Forecast To 2026

About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Jesus Rust

By Jesus Rust

Jesus is leading the environment column. He is a very renowned environmentalist and has worked in many projects, some of which are based in faraway lands too. He always encourages environment conservation and sometimes keeps small group talks about the concerns. His writing and editing skills act the cheery on the top of the cake.

Leave a Reply

Your email address will not be published. Required fields are marked *